Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people

Lancet

Volumn 351, Issue 9112, 1998, Pages 1303-1307

  Liu, Barbara ^a   Anderson, Geoff ^a   Mittmann, Nicole ^a   To, Teresa ^a   Axcell, Tami ^a   Shear, Neil ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

AGED; ARTICLE; CANADA; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG USE; FALLING; FEMALE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK;

EID: 0032474241     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)09528-7     Document Type: Article

References (34)

1. 1 Liu BA, Topper AK, Reeves RA, Gryfe C, Maki BE. Falls among older people: relationship to medication use and orthostatic hypotension. J Am Geriatr Soc 1995; 43: 1141-45.
2. 2 Gales BH, Menard SM. Relationship between the administration of selected medications and falls in hospitalized elderly patients. Ann Pharmacother 1995; 29: 354-58.
3. 3 Lord SR, Anstey KH, Williams P, Ward JA. Psychoactive medication use, sensori-motor function and falls in older women. Br J Clin Pharmacol 1995; 39: 227-34.
4. 4 Ruthazer R, Lipsitz AL. Antidepressants and falls among elderly people in long-term care. Am J Public Health 1993; 93: 746-49.
5. 5 Ray WA, Griffin MR, Schaffiier W, Baugh DK, Melton LJ III. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316: 363-69.
6. 6 Ray WA, Griffin MR, Malcolm E. Cyclic antidepressants and the risk of hip fracture. Arch Intern Med 1991; 151: 754-56.
7. 7 Tinetti ME, Ginter SF. Identifying mobility dysfunctions in elderly patients. JAMA 1988; 259: 1190-93.
8. 8 Throngren KG, Ceder L, Svensson K. Predicting results of rehabilitation after hip fracture: a ten-year follow-up study. Clin Orthop 1993; 287: 76-81.
9. 9 Clayer MT, Bauze RJ. Morbidity and mortality following fractures of the femoral neck and trochanteric region: analysis of risk factors. J Trauma 1989; 29: 1673-78.
10. 10 Cummings SR, Kelsey JL, Nevitt MC, et al. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178-208.
11. 11 Nevitt MC. Epidemiology of osteoporosis. Rheum Dis Clin North Am 1994; 20: 535-59.
12. 12 Greendale GA, Barrett-Connor E, Ingles S, Haile R. Late physical and functional effects of osteoporotic fracture in women: the Rancho Bernardo Study. J Am Greriatr Soc 1995; 43: 955-61.
13. 13 Anderson G, Carter JA. Patterns of use of specific drugs in the elderly: antidepressants, antibiotics and drugs to be avoided in the elderly. In: Goel V, Williams J, Anderson G, et al, eds. Patterns of health care in Ontario: ICES practice atlas. 2nd edn. Ottawa: Canadian Medical Association, 1996; 323-28.
14. 14 de Jonghe F, Swinkels JA. The safety of antidepressants. Drugs 1992; 43 (suppl 2): 40-47.
15. 15 Levinson ML, Lipsy RJ, Fuller DK. Adverse effects and drug interactions associated with fluoxetine therapy. Drug Intelligence Clin Pharmacy 1991; 25: 657-61.
16. 16 Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993; 306: 683-87.
17. 17 Mittmann N, Herrmann N, Einarson TR, et al. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Disord 1997; 46: 191-217.
18. 18 Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995; 310: 1433-38.
19. 19 The international classification of diseases, 9th revision. Clinical modification: ICD-9-CM. Ann Arbor, Michigan: Commission of Professional and Hospital Activities, 1978.
20. 20 ATC Index. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology, 1991.
21. 21 Tinetti ME, Speechley M. Prevention of falls among the elderly. N Engl J Med 1989; 320: 1055-59.
22. 22 Rubenstein LZ, Josephson KR, Robbins AS. Falls in the nursing home. Ann Intern Med 1994; 121: 442-51.
23. 23 Herings RM, Stricker BHC, DeBoer A, Bakker A, Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures. Arch Intern Med 1995; 155: 1801-07.
24. 24 Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-19.
25. 25 Campbell AJ. Drug treatment as a cause of falls in old age: a review of the offending agents. Drugs Aging 1991; 1: 289-302.
26. 26 Macdonald JB. The role of drugs in falls in the elderly. Clin Geriat Med 1985; 1: 621-36.
27. 27 Ray WA, Griffin MR, West R, Strand L, Melton LJ III. Incidence of hip fracture in Saskatchewan, Canada,1976-1985. Am J Epidemiol 1990; 131: 502-09.
28. 28 Williams JI, Young W. Summary of studies on the quality of health care administrative data in Canada. In: Goel V, Williams J, Anderson G, et al, eds. Patterns of health care in Ontario: ICES practice atlas. 2nd edn. Ottawa: Canadian Medical Association, 1996: 339-46.
29. 29 Preskorn SH, Lane RM. Sertraline 50 mg daily: the optimal dose in the treatment of depression. Int Clin Psychopharmacol 1995; 10: 129-41.
30. 30 Sulser F. Mode of action of antidepressant drugs. J Clin Psychiatry 1983; 44: 14-20.
31. 31 Leonard B. The comparative pharmacology of new antidepressants. J Clin Psychiatry 1993; 54 (suppl 8): 3-15.
32. 32 Michelson D, Stratakis C, Hill L, et al. Bone mineral density in women with depression. N Engl J Med 1996; 335: 1176-81.
33. 33 Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825-32.
34. 34 Preskorn SH. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med 1993; 94 (suppl 5A): 2S-12S.